1.705
price down icon10.73%   -0.205
after-market アフターアワーズ: 1.71 0.005 +0.29%
loading
前日終値:
$1.91
開ける:
$1.8
24時間の取引高:
1.09M
Relative Volume:
0.74
時価総額:
$120.98M
収益:
-
当期純損益:
$-117.50M
株価収益率:
-0.7104
EPS:
-2.4
ネットキャッシュフロー:
$-114.31M
1週間 パフォーマンス:
-13.45%
1か月 パフォーマンス:
+5.25%
6か月 パフォーマンス:
-56.28%
1年 パフォーマンス:
-82.02%
1日の値動き範囲:
Value
$1.70
$1.835
1週間の範囲:
Value
$1.70
$2.12
52週間の値動き範囲:
Value
$1.31
$10.16

Nkarta Inc Stock (NKTX) Company Profile

Name
名前
Nkarta Inc
Name
セクター
Healthcare (1174)
Name
電話
(925) 407-1049
Name
住所
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Name
職員
0
Name
Twitter
Name
次回の収益日
2025-03-26
Name
最新のSEC提出書
Name
NKTX's Discussions on Twitter

NKTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NKTX
Nkarta Inc
1.705 120.98M 0 -117.50M -114.31M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Nkarta Inc Stock (NKTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-09 開始されました Rodman & Renshaw Buy
2024-08-14 アップグレード Raymond James Outperform → Strong Buy
2024-03-22 ダウングレード Raymond James Strong Buy → Outperform
2022-12-22 ダウングレード Oppenheimer Outperform → Perform
2022-10-10 開始されました Canaccord Genuity Buy
2022-07-28 開始されました Needham Buy
2022-07-18 開始されました SVB Leerink Outperform
2022-03-11 開始されました Raymond James Outperform
2022-03-08 開始されました H.C. Wainwright Buy
2022-01-06 開始されました William Blair Outperform
2021-11-18 開始されました SMBC Nikko Outperform
2021-07-16 開始されました Oppenheimer Outperform
2020-08-04 開始されました Cowen Outperform
2020-08-04 開始されました Evercore ISI Outperform
2020-08-04 開始されました Mizuho Buy
2020-08-04 開始されました Stifel Buy
すべてを表示

Nkarta Inc (NKTX) 最新ニュース

pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Cuts Stock Holdings in Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Nkarta to Participate in an April Investor Conference - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

NK Cell Pioneer Nkarta Takes Center Stage at Major Healthcare Conference - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Leerink Partnrs Has Bullish Outlook for Nkarta Q1 Earnings - The AM Reporter

Apr 01, 2025
pulisher
Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025
pulisher
Mar 31, 2025

Nkarta: Grinding Lower, Trying To Find Support (NASDAQ:NKTX) - Seeking Alpha

Mar 31, 2025
pulisher
Mar 31, 2025

Nkarta: Betting On The Turnaround (NASDAQ:NKTX) - Seeking Alpha

Mar 31, 2025
pulisher
Mar 31, 2025

Leerink Partnrs Has Strong Forecast for Nkarta Q1 Earnings - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

What is HC Wainwright’s Forecast for Nkarta Q1 Earnings? - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Nkarta, Inc. (NASDAQ:NKTX) Receives $14.86 Average Price Target from Brokerages - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

Stifel Nicolaus Has Lowered Expectations for Nkarta (NASDAQ:NKTX) Stock Price - Defense World

Mar 29, 2025
pulisher
Mar 29, 2025

HC Wainwright Reiterates Buy Rating for Nkarta (NASDAQ:NKTX) - Defense World

Mar 29, 2025
pulisher
Mar 27, 2025

Nkarta’s Strategic Workforce Reduction and Clinical Progress Justify Buy Rating - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Analysts Adjust Price Targets For Nkarta And Bicara - Evrim Ağacı

Mar 27, 2025
pulisher
Mar 27, 2025

Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday? - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

Analysts Offer Insights on Healthcare Companies: Allurion Technologies (ALUR), Perspective Therapeutics (CATX) and Nkarta (NKTX) - The Globe and Mail

Mar 27, 2025
pulisher
Mar 27, 2025

Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy - BioPharma Dive

Mar 27, 2025
pulisher
Mar 27, 2025

Stifel cuts Nkarta stock price target to $14, maintains buy rating - Investing.com India

Mar 27, 2025
pulisher
Mar 27, 2025

Nkarta to lay off 34% of staff; Savara’s debt financing deal - Endpoints News

Mar 27, 2025
pulisher
Mar 27, 2025

H.C. Wainwright maintains Buy on Nkarta stock with $18 target - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Nkarta lays off 3rd of staff to fund autoimmune CAR NK program - Fierce Biotech

Mar 27, 2025
pulisher
Mar 27, 2025

Newly pivoted to autoimmune, Nkarta trims staff by over third - FirstWord Pharma

Mar 27, 2025
pulisher
Mar 27, 2025

Nkarta’s Strategic Restructuring and NKX019 Progress Drive Buy Rating - TipRanks

Mar 27, 2025
pulisher
Mar 26, 2025

Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Nkarta Posts Narrower Q4 Loss; Discloses Restructuring Plan - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Nkarta Announces Major Restructuring and Leadership Changes - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Nkarta Inc To Reduce Workforce By 34%, Impacting 53 PositionsSEC Filing - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Nkarta Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

Nkarta's Strategic Reset: 34% Staff Cut Powers 5-Year Cash Runway with $380M War Chest - Stock Titan

Mar 26, 2025
pulisher
Mar 26, 2025

TD Cowen Keeps Their Buy Rating on Nkarta (NKTX) - The Globe and Mail

Mar 26, 2025
pulisher
Mar 21, 2025

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

Nkarta (NKTX) Loses -33.62% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Mar 20, 2025
pulisher
Mar 19, 2025

Nkarta (NKTX) Loses -32.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Mar 19, 2025
pulisher
Mar 17, 2025

Nkarta Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView

Mar 17, 2025
pulisher
Mar 13, 2025

Nkarta (NKTX) Projected to Post Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 03, 2025

NKTX stock touches 52-week low at $1.69 amid market challenges - Investing.com

Mar 03, 2025
pulisher
Mar 01, 2025

Comparing Tempest Therapeutics (NASDAQ:TPST) & Nkarta (NASDAQ:NKTX) - Defense World

Mar 01, 2025
pulisher
Feb 27, 2025

Will Nkarta (NASDAQ:NKTX) Spend Its Cash Wisely? - Simply Wall St

Feb 27, 2025
pulisher
Feb 25, 2025

Nkarta to Participate in March Investor Conferences - The Manila Times

Feb 25, 2025
pulisher
Feb 24, 2025

NKTX stock touches 52-week low at $1.96 amid market challenges - Investing.com

Feb 24, 2025
pulisher
Feb 18, 2025

Leerink Partnrs Forecasts Nkarta FY2029 Earnings - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

Leerink Partnrs Comments on Nkarta FY2024 Earnings - Defense World

Feb 17, 2025
pulisher
Feb 16, 2025

Leerink Partnrs Comments on Nkarta FY2029 Earnings - Defense World

Feb 16, 2025
pulisher
Feb 15, 2025

Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Feb 15, 2025
pulisher
Feb 11, 2025

Stock Performance Spotlight: Nkarta Inc (NKTX) Ends the Day at 2.09, Down by -3.69 - The Dwinnex

Feb 11, 2025
pulisher
Feb 11, 2025

Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Rating of “Buy” by Brokerages - Defense World

Feb 11, 2025
pulisher
Feb 06, 2025

A new trading data show Nkarta Inc (NKTX) is showing positive returns. - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Vasculitis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | R-Pharm Overseas, Abbvie, Toleranzia, Ambulero, Visterra, CytoDyn - The Globe and Mail

Feb 06, 2025
pulisher
Feb 05, 2025

Monitoring Nkarta Inc (NKTX) after recent insider movements - Knox Daily

Feb 05, 2025
pulisher
Feb 04, 2025

The Potential Rise in the Price of Trane Technologies plc (TT) following insiders activity - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Closing Figures: Nkarta Inc (NKTX)’s Negative Finish at 2.17, Down -7.26 - The Dwinnex

Feb 04, 2025

Nkarta Inc (NKTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
大文字化:     |  ボリューム (24 時間):